RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma

Adjuvant transcatheter arterial chemoembolization (TACE) protects against hepatocellular carcinoma (HCC) and is associated with reduced disease recurrence and improved outcome after surgery. However, deterioration of liver function after TACE negatively impacts the patient prognosis and limits it us...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Jiang, Tian-Yi, Jiang, Bei-Ge, Yang, Chun, Tan, Ye-Xiong, Yang, Ning, Pan, Yu-Fei, Ding, Zhi-Wen, Yang, Guang-Zhen, Wu, Meng-Chao, Dong, Li-Wei, Wang, Hong-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413664/
https://www.ncbi.nlm.nih.gov/pubmed/25605019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413664/
https://www.ncbi.nlm.nih.gov/pubmed/25605019

Ejemplares similares